At a glance
ClinicalIndex Comparison RecordN/ACompleted· 355 enrolled
Drug / intervention
Quikclot Radial (QC) Paddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Comparison of the QuikClot® Radial® Pad Versus the Standard of Care TR Band® on Hemostasis After Transradial Artery Access
In Brief
A clinical study evaluating Quikclot Radial (QC) Pad for Coronary Artery Disease. Completed, enrolled 355 participants across 1 site.
Detailed Summary
To evaluate the efficacy and safety of the QuikClot® Radial® pad on hemostasis after transradial access (TRA), compared to the standard of care TR Band®, to hopefully develop a safe and efficacious technique to achieve more rapid patent hemostasis after TRA, and improve patient care by optimizing radial hemostasis management.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesUnited States
CollaboratorsZ-Medica
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 2018
Enrollment StartAug 2018
Primary CompletionDec 2022
TodayJul 2026
First PostedMay 24, 2018
Enrollment StartAug 1, 2018
Primary CompletionDec 28, 2022
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 8.1 years ago
Interventions
Quikclot Radial (QC) Paddevice
The QC pad will be applied over the radial artery access site covered with either a Coban™ bandage, a Tegaderm™ dressing, or a TR Band after TRA.